Welcome To RobinsPost.com

FLYING AROUND THE INTERNET FOR RELATED NEWS VIDEOS.

Related News Videos From Youtube For:

Pracinostat and Acute Myeloid Leukemia - Preliminary Data is Encouraging



Pracinostat is a histone deacetylase (HDAC) inhibitor being developed for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this exclusive interview with Rare Disease Report, Guillermo Garcia-Manero, MD of University of Texas MD Anderson Cancer Center talks about data his group presented at American Society of Hematology (ASH) annual meeting showing the combination of pracinostat plus azacitidine may improve outcomes in older patients with AML. Reference Garcia-Manero G, Atallah, E, Odenike O et al, Pracinostat in Combination with Azacitidine Produces a High Rate and Rapid Onset of Disease Remission in Patients with Previously Untreated Acute Myeloid Leukemia (AML). Presented at” American Society Hematology Annual Meeting; December 6-9,2014; SanFrancisco CA. Abstract 947.

Why curing cancer is so hard | Azra Raza | TEDxNewYork


Acute Myeloid Leukemia -- Treatment


What is "MDS"? (Myelodysplastic Syndromes)


Acute myeloid leukemia (AML) - a life threatening cancer


Acute Myelogenous Leukemia (AML) Survivor: Danel Lawrence


Una Vision General de los Sindromes Mielodisplasicos


Terry Ikner- Diagnosed with AML APL Leukemia


Leukemia AML MDS Moon Shots update


Pracinostat and azacitidine for elderly AML


Myelodysplastic syndrome (MDS) survivor Holly Easley shares her thoughts on the Moon Shots Program